Nykode Therapeutics AS (OSL: NYKD)
Norway
· Delayed Price · Currency is NOK 2.770
+0.020 (0.73%)
Nov 21, 2024, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 898.00 million as of November 21, 2024. Its market cap has decreased by -84.73% in one year.
Market Cap
898.00M
Enterprise Value
-505.96M
Revenue
69.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.77
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 898.00M, a decrease of -83.74%. That is a compound annual growth rate of -31.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 898.00M | -87.15% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
| Jan 28, 2020 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nordhealth AS | 2.96B |
| Medistim ASA | 2.42B |
| Photocure ASA | 1.43B |
| Carasent ASA | 1.41B |
| ArcticZymes Technologies ASA | 696.61M |
| Gentian Diagnostics ASA | 650.82M |
| Hofseth BioCare ASA | 557.01M |
| Navamedic ASA | 418.61M |